|
5-fluorouracil (5-FU) Clinical Trials
10 actively recruiting trials across 8 locations
Also known as: ADRUCIL®
Pipeline
Phase 1: 4Phase 2: 2Phase 3: 1Phase 1/2: 3
Top Sponsors
- Merck Sharp & Dohme LLC2
- AstraZeneca2
- toqa saad mohammed mohammed1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
- Seagen, a wholly owned subsidiary of Pfizer1
Indications
- Cancer10
- Gastroesophageal Adenocarcinoma2
- Carcinoma, Non-Small-Cell Lung2
- Colorectal Neoplasms2
- Colorectal Cancer2
Other2 trials
Phoenix, Arizona1 trial
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Mayo Clinic Hospital
Phase 1
Tucson, Arizona1 trial
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927)
Phase 1/2
Cerritos, California1 trial
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
TOI Clinical Research
Phase 3
Duarte, California1 trial
First in Human Study of AZD9592 in Solid Tumors
Research Site
Phase 1
Encinitas, California1 trial
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
California Cancer Associates for Research & Excellence, Inc.
Phase 1
Newark, Delaware1 trial
Baltimore, Maryland1 trial
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center
Phase 2
Pittsburgh, Pennsylvania1 trial
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
UPMC Hillman Cancer Center ( Site 1904)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.